Comments
Loading...
AtriCure Stock Guidance | NASDAQ:ATRC | Benzinga
AtriCure issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/26/2025 | ATRC | AtriCure | FY | 2030 | — | — | — | $1.00B | $1.00B | — | Get Alert |
| 03/26/2025 | ATRC | AtriCure | FY | 2028 | — | — | — | $750.00M | — | — | Get Alert |
| 02/12/2025 | ATRC | AtriCure | FY | 2025 | -$0.64 | -$0.57 | -$0.60 | $517.00M | $527.00M | $522.56M | Get Alert |
| 01/13/2025 | ATRC | AtriCure | FY | 2025 | — | — | — | $517.00M | $527.00M | $522.81M | Get Alert |
| 01/13/2025 | ATRC | AtriCure | Q4 | 2024 | — | — | — | $124.30M | $124.30M | $119.85M | Get Alert |
| 01/13/2025 | ATRC | AtriCure | FY | 2024 | -$0.80 | -$0.74 | -$0.74 | $465.30M | $465.30M | $460.89M | Get Alert |
| 10/29/2024 | ATRC | AtriCure | FY | 2024 | -$0.80 | -$0.74 | -$0.79 | $459.00M | $462.00M | $458.11M | Get Alert |
| 07/30/2024 | ATRC | AtriCure | FY | 2024 | -$0.82 | -$0.74 | -$0.78 | $456.00M | $461.00M | $461.98M | Get Alert |
| 05/01/2024 | ATRC | AtriCure | FY | 2024 | -$0.82 | -$0.74 | -$0.74 | $459.00M | $466.00M | $461.30M | Get Alert |
| 02/15/2024 | ATRC | AtriCure | FY | 2024 | -$0.82 | -$0.74 | -$0.69 | $459.00M | $466.00M | $455.86M | Get Alert |
| 01/08/2024 | ATRC | AtriCure | Q4 | 2023 | — | — | — | $106.50M | $106.50M | $102.43M | Get Alert |
| 01/08/2024 | ATRC | AtriCure | FY | 2023 | — | — | — | $399.20M | $399.20M | $395.16M | Get Alert |
| 01/08/2024 | ATRC | AtriCure | FY | 2024 | — | — | — | $459.00M | $466.00M | $454.68M | Get Alert |
| 11/01/2023 | ATRC | AtriCure | FY | 2023 | -$0.76 | -$0.74 | -$0.92 | $394.00M | $396.00M | $393.87M | Get Alert |
| 07/25/2023 | ATRC | AtriCure | FY | 2023 | -$0.94 | -$0.92 | -$1.02 | $392.00M | $395.00M | $388.31M | Get Alert |
| 05/02/2023 | ATRC | AtriCure | FY | 2023 | -$1.15 | -$1.10 | -$1.10 | $385.00M | $392.00M | $382.67M | Get Alert |
| 02/21/2023 | ATRC | AtriCure | FY | 2023 | -$1.19 | -$1.14 | -$0.84 | $380.00M | $387.00M | $381.70M | Get Alert |
| 01/09/2023 | ATRC | AtriCure | FY | 2023 | — | — | — | $380.00M | $387.00M | $380.03M | Get Alert |
| 01/09/2023 | ATRC | AtriCure | Q4 | 2022 | — | — | — | $88.00M | $88.00M | $87.66M | Get Alert |
| 01/09/2023 | ATRC | AtriCure | FY | 2022 | -$1.12 | -$1.10 | -$1.10 | $330.40M | $330.40M | $330.06M | Get Alert |
| 11/01/2022 | ATRC | AtriCure | FY | 2022 | -$1.12 | -$1.10 | -$1.10 | $328.00M | $333.00M | $328.61M | Get Alert |
| 08/02/2022 | ATRC | AtriCure | FY | 2022 | -$1.12 | -$1.07 | -$1.10 | $323.00M | $333.00M | $324.43M | Get Alert |
| 05/03/2022 | ATRC | AtriCure | FY | 2022 | -$1.12 | -$1.07 | -$1.05 | $318.00M | $330.00M | $321.65M | Get Alert |
| 02/15/2022 | ATRC | AtriCure | FY | 2022 | — | — | — | $315.00M | $330.00M | $319.44M | Get Alert |
| 01/10/2022 | ATRC | AtriCure | FY | 2021 | — | — | — | $274.30M | $274.30M | $273.57M | Get Alert |
| 01/10/2022 | ATRC | AtriCure | Q4 | 2021 | — | — | — | $73.20M | $73.20M | $72.53M | Get Alert |
| 01/10/2022 | ATRC | AtriCure | FY | 2022 | — | — | — | $315.00M | $330.00M | $321.67M | Get Alert |
| 11/03/2021 | ATRC | AtriCure | FY | 2021 | -$1.20 | -$1.20 | -$1.35 | $270.00M | $275.00M | $272.94M | Get Alert |
| 08/04/2021 | ATRC | AtriCure | FY | 2021 | -$1.20 | -$1.20 | -$1.25 | $270.00M | $275.00M | $254.77M | Get Alert |
| 04/27/2021 | ATRC | AtriCure | FY | 2021 | -$1.15 | -$1.15 | -$1.16 | $252.00M | $256.00M | $250.29M | Get Alert |
| 02/23/2021 | ATRC | AtriCure | Q1 | 2021 | -$0.39 | -$0.36 | -$0.21 | $55.00M | $57.00M | $59.31M | Get Alert |
| 02/23/2021 | ATRC | AtriCure | FY | 2021 | -$1.15 | -$1.15 | -$0.82 | $250.00M | $250.00M | $257.10M | Get Alert |
| 01/11/2021 | ATRC | AtriCure | FY | 2020 | — | — | — | $206.50M | $206.50M | $206.93M | Get Alert |
| 01/11/2021 | ATRC | AtriCure | Q4 | 2020 | — | — | — | $57.70M | $57.70M | $58.10M | Get Alert |
| 11/05/2020 | ATRC | AtriCure | Q4 | 2020 | — | — | — | $56.00M | $60.00M | $62.05M | Get Alert |
| 11/05/2020 | ATRC | AtriCure | FY | 2020 | — | — | — | $205.00M | $209.00M | $205.45M | Get Alert |
FAQ
What is the most recent guidance for AtriCure (ATRC)?
The most recent guidance for AtriCure (ATRC) was reported on February 12, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $-0.64 to $-0.57, compared to the estimated EPS of $-0.60. Additionally, AtriCure forecasted revenue between $0.52B and $0.53B for the quarter.
Browse guidance and forecast on all stocks.